ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease
The ABSORB trials have grabbed the limelight for years. Now C. Michael Gibson hears about the 3 year ABSORB III results from Stephen G. Ellis.